{
  "metadata": {
    "generated_at": "2025-10-02T06:33:55.728259",
    "dataset": {
      "name": "pharmacy_copilot_pharmacist_eval_v1",
      "description": "Gold pharmacist scenarios for LLM evaluation (enriched for deterministic scoring).",
      "version": "1.2.0"
    },
    "evaluation_time": 48.71250581741333,
    "judge_summary": {
      "mean_score": 66.92307692307692,
      "median_score": 75,
      "count": 13
    }
  },
  "aggregated_metrics": {
    "retrieval": {
      "recall_at_k": {
        "1": 0.6538461538461539,
        "3": 0.9230769230769231,
        "5": 0.9230769230769231,
        "10": 0.9230769230769231,
        "20": 0.9230769230769231
      },
      "precision_at_k": {
        "1": 0.9230769230769231,
        "3": 0.5897435897435896,
        "5": 0.5897435897435896,
        "10": 0.5897435897435896,
        "20": 0.5897435897435896
      },
      "mean_reciprocal_rank": 0.9230769230769231,
      "average_precision": 0.9230769230769231,
      "ndcg_at_k": {
        "1": 0.9230769230769231,
        "3": 0.9230769230769231,
        "5": 0.9230769230769231,
        "10": 0.9230769230769231,
        "20": 0.9230769230769231
      },
      "essential_recall_at_k": {
        "1": 0.9230769230769231,
        "3": 0.9230769230769231,
        "5": 0.9230769230769231,
        "10": 0.9230769230769231,
        "20": 0.9230769230769231
      },
      "first_relevant_rank": 0.9230769230769231,
      "total_relevant": 19,
      "total_essential": 12
    },
    "qa": {
      "bleu_score": 0.02147862715631924,
      "rouge_1_f1": 0.31353083311083935,
      "rouge_2_f1": 0.12086691736611839,
      "rouge_l_f1": 0.19415719887338084,
      "semantic_similarity": 0.5043551474809647,
      "key_points_covered": 0.1346153846153846,
      "key_points_found": [],
      "key_points_missing": [],
      "answer_length": 15,
      "has_answer": true,
      "factual_accuracy": null,
      "helpfulness": null
    }
  },
  "detailed_results": [
    {
      "question_id": "q001",
      "question": "5-year-old (18 kg) with acute otitis media. What is the amoxicillin dose and volume using 400 mg/5 mL suspension?",
      "llm_response": {
        "raw_answer": "{\"dose_per_dose_mg\":810,\"volume_per_dose_mL\":10.1,\"frequency\":\"q12h\",\"max_daily_mg\":4000,\"rounding\":\"round to practical mL\",\"calc_rule\":\"90 mg/kg/day divided q12h\",\"citations\":[\"lexi-amoxicillin-2018#dosage\",\"lexi-amoxicillin-2018#peds\"],\"notes\":\"High-dose amoxicillin for pediatric AOM.\"}",
        "parsed_answer": {
          "dose_per_dose_mg": 810,
          "volume_per_dose_mL": 10.1,
          "frequency": "q12h",
          "max_daily_mg": 4000,
          "rounding": "round to practical mL",
          "calc_rule": "90 mg/kg/day divided q12h",
          "citations": [
            "lexi-amoxicillin-2018#dosage",
            "lexi-amoxicillin-2018#peds"
          ],
          "notes": "High-dose amoxicillin for pediatric AOM."
        },
        "failure_types": [
          "qa_incomplete"
        ]
      },
      "expected_answer": "Amoxicillin 90 mg/kg/day divided q12h \u2192 810 mg per dose (\u224810.1 mL of 400 mg/5 mL), round to 10 mL per dose; max 4 g/day.",
      "judge_assessment": {
        "score": 85,
        "verdict": "pass",
        "rationale": "The answer correctly provides the dose, frequency, max daily mg, and volume with acceptable rounding. It cites allowed chunks and covers all clinically substantive fields."
      },
      "retrieval_performance": {
        "retrieved_chunks": [
          {
            "chunk_id": "lexi-amoxicillin-2018#dosage",
            "score": 0.0,
            "rank": 1
          },
          {
            "chunk_id": "lexi-amoxicillin-2018#peds",
            "score": 0.0,
            "rank": 2
          },
          {
            "chunk_id": "lexi-amoxicillin-2018#adult-sinusitis",
            "score": 0.0,
            "rank": 3
          }
        ],
        "relevant_chunks_found": [
          "lexi-amoxicillin-2018#dosage",
          "lexi-amoxicillin-2018#peds"
        ],
        "essential_chunks_missed": []
      },
      "key_points_missing": [
        "Uses high-dose 80\u201390 mg/kg/day regimen",
        "BID (q12h) frequency",
        "Per-dose \u2248810 mg for 18 kg",
        "Volume \u224810.1 mL from 400 mg/5 mL (80 mg/mL); rounding to 10 mL OK",
        "Max daily 4 g acknowledged",
        "No renal adjustment if normal function",
        "Cites pediatric dosage section"
      ]
    },
    {
      "question_id": "q002",
      "question": "12 kg child with fever: acetaminophen dose and volume using 160 mg/5 mL?",
      "llm_response": {
        "raw_answer": "```json\n{\"dose_per_dose_mg\":180,\"volume_per_dose_mL\":5.6,\"frequency\":\"q6h\",\"max_daily_mg\":900,\"rounding\":\"mL rounded to one decimal\",\"calc_rule\":\"15 mg/kg/dose for 12 kg child\",\"citations\":[\"lexi-acetaminophen-2018#peds-dosing\",\"lexi-acetaminophen-2018#max\"],\"notes\":\"Use 15 mg/kg/dose for fever in children.\"}\n```",
        "parsed_answer": "```json\n{\"dose_per_dose_mg\":180,\"volume_per_dose_mL\":5.6,\"frequency\":\"q6h\",\"max_daily_mg\":900,\"rounding\":\"mL rounded to one decimal\",\"calc_rule\":\"15 mg/kg/dose for 12 kg child\",\"citations\":[\"lexi-acetaminophen-2018#peds-dosing\",\"lexi-acetaminophen-2018#max\"],\"notes\":\"Use 15 mg/kg/dose for fever in children.\"}\n```",
        "failure_types": [
          "qa_incorrect",
          "qa_incomplete",
          "e2e_low_quality"
        ]
      },
      "expected_answer": "Acetaminophen 15 mg/kg/dose q6h (range 10\u201315 mg/kg q4\u20136h) \u2192 180 mg per dose \u22485.6 mL of 160 mg/5 mL; max 75 mg/kg/day (900 mg), and \u22644 g absolute.",
      "judge_assessment": {
        "score": 0,
        "verdict": "manual_review",
        "rationale": "Judge response not JSON: ```json\n{\n  \"score\": 85,\n  \"verdict\": \"pass\",\n  \"rationale\": \"The answer correctly provides the dose, volume, frequency,..."
      },
      "retrieval_performance": {
        "retrieved_chunks": [
          {
            "chunk_id": "lexi-acetaminophen-2018#peds-dosing",
            "score": 0.0,
            "rank": 1
          },
          {
            "chunk_id": "lexi-acetaminophen-2018#max",
            "score": 0.0,
            "rank": 2
          },
          {
            "chunk_id": "lexi-acetaminophen-2018#rectal",
            "score": 0.0,
            "rank": 3
          }
        ],
        "relevant_chunks_found": [
          "lexi-acetaminophen-2018#max",
          "lexi-acetaminophen-2018#peds-dosing"
        ],
        "essential_chunks_missed": []
      },
      "key_points_missing": [
        "Per-dose 15 mg/kg used",
        "q4\u20136h acceptable; target q6h in calc",
        "180 mg per dose for 12 kg",
        "Volume \u22485.625 mL from 32 mg/mL",
        "Daily max 75 mg/kg/day and \u22644 g",
        "Pediatric dosing section cited"
      ]
    },
    {
      "question_id": "q003",
      "question": "12 kg child with fever: ibuprofen dose and volume using 100 mg/5 mL?",
      "llm_response": {
        "raw_answer": "{\"dose_per_dose_mg\":120,\"volume_per_dose_mL\":6,\"frequency\":\"q6\u20138h\",\"max_daily_mg\":480,\"rounding\":\"whole mL\",\"calc_rule\":\"10 mg/kg/dose\",\"citations\":[\"lexi-ibuprofen-2018#peds-dosing\",\"lexi-ibuprofen-2018#max\"],\"notes\":\"Use oral suspension for pediatric dosing.\"}",
        "parsed_answer": {
          "dose_per_dose_mg": 120,
          "volume_per_dose_mL": 6,
          "frequency": "q6\u20138h",
          "max_daily_mg": 480,
          "rounding": "whole mL",
          "calc_rule": "10 mg/kg/dose",
          "citations": [
            "lexi-ibuprofen-2018#peds-dosing",
            "lexi-ibuprofen-2018#max"
          ],
          "notes": "Use oral suspension for pediatric dosing."
        },
        "failure_types": [
          "qa_incorrect",
          "qa_incomplete",
          "e2e_low_quality"
        ]
      },
      "expected_answer": "Ibuprofen 10 mg/kg/dose q6\u20138h \u2192 120 mg per dose (6 mL of 100 mg/5 mL); max 40 mg/kg/day (480 mg). Avoid if <6 months or dehydrated/renal issues.",
      "judge_assessment": {
        "score": 75,
        "verdict": "manual_review",
        "rationale": "The answer correctly identifies the dose, volume, frequency, and max daily mg, but the rounding rule is incorrectly stated as 'whole mL' instead of '6 mL'. The notes contain a claim about using oral suspension, which is not directly supported by the cited chunks."
      },
      "retrieval_performance": {
        "retrieved_chunks": [
          {
            "chunk_id": "lexi-ibuprofen-2018#peds-dosing",
            "score": 0.0,
            "rank": 1
          },
          {
            "chunk_id": "lexi-ibuprofen-2018#max",
            "score": 0.0,
            "rank": 2
          },
          {
            "chunk_id": "lexi-ibuprofen-2018#adult-capsules",
            "score": 0.0,
            "rank": 3
          }
        ],
        "relevant_chunks_found": [
          "lexi-ibuprofen-2018#max",
          "lexi-ibuprofen-2018#peds-dosing"
        ],
        "essential_chunks_missed": []
      },
      "key_points_missing": [
        "10 mg/kg per dose",
        "120 mg per dose for 12 kg",
        "6 mL at 20 mg/mL",
        "Max 40 mg/kg/day (480 mg)",
        "Contraindication: <6 months; caution renal/dehydration"
      ]
    },
    {
      "question_id": "q004",
      "question": "Elderly patient with nonvalvular AF: 82 years, 58 kg, SCr 1.6 mg/dL. What apixaban dose?",
      "llm_response": {
        "raw_answer": "{\"dose_per_dose_mg\":2.5,\"volume_per_dose_mL\":null,\"frequency\":\"q12h\",\"max_daily_mg\":5,\"rounding\":\"none\",\"calc_rule\":\"2 of 3 criteria met: age \u226580 years, weight \u226460 kg, serum creatinine \u22651.5 mg/dL\",\"citations\":[\"lexi-apixaban-2018#dosing-nvaf\"],\"notes\":\"Apixaban dose reduced due to age, weight, and renal function.\"}",
        "parsed_answer": {
          "dose_per_dose_mg": 2.5,
          "volume_per_dose_mL": null,
          "frequency": "q12h",
          "max_daily_mg": 5,
          "rounding": "none",
          "calc_rule": "2 of 3 criteria met: age \u226580 years, weight \u226460 kg, serum creatinine \u22651.5 mg/dL",
          "citations": [
            "lexi-apixaban-2018#dosing-nvaf"
          ],
          "notes": "Apixaban dose reduced due to age, weight, and renal function."
        },
        "failure_types": [
          "qa_incorrect",
          "qa_incomplete",
          "e2e_low_quality"
        ]
      },
      "expected_answer": "Apixaban 2.5 mg BID (meets 2 of 3: age \u226580, weight \u226460 kg, SCr \u22651.5). Avoid with strong CYP3A4/P-gp inhibitors.",
      "judge_assessment": {
        "score": 75,
        "verdict": "manual_review",
        "rationale": "The answer correctly identifies the dose of apixaban as 2.5 mg BID and cites the appropriate chunk for dose reduction criteria. However, it fails to mention the interaction with strong CYP3A4/P-gp inhibitors, which is a critical safety point. The max daily mg is correctly stated as 5 mg, but the rounding rule is not applicable here. Overall, the answer is mostly correct but lacks completeness in safety considerations."
      },
      "retrieval_performance": {
        "retrieved_chunks": [
          {
            "chunk_id": "lexi-apixaban-2018#dosing-nvaf",
            "score": 0.0,
            "rank": 1
          },
          {
            "chunk_id": "lexi-apixaban-2018#ddi",
            "score": 0.0,
            "rank": 2
          },
          {
            "chunk_id": "lexi-apixaban-2018#vte",
            "score": 0.0,
            "rank": 3
          }
        ],
        "relevant_chunks_found": [
          "lexi-apixaban-2018#ddi",
          "lexi-apixaban-2018#dosing-nvaf"
        ],
        "essential_chunks_missed": []
      },
      "key_points_missing": [
        "Dose reduction criteria (2 of 3)",
        "Final dose 2.5 mg BID",
        "Interaction caveat: strong CYP3A4/P-gp",
        "Hepatic impairment caution"
      ]
    },
    {
      "question_id": "q005",
      "question": "85 kg adult with acute DVT: What is the enoxaparin treatment dose (normal renal function)?",
      "llm_response": {
        "raw_answer": "{\"dose_per_dose_mg\":85,\"volume_per_dose_mL\":null,\"frequency\":\"q12h\",\"max_daily_mg\":170,\"rounding\":\"nearest whole mg\",\"calc_rule\":\"1 mg/kg q12h\",\"citations\":[\"lexi-enoxaparin-2018#dosing\"],\"notes\":\"Enoxaparin 1 mg/kg SC q12h is the preferred regimen for acute DVT treatment in normal renal function.\"}",
        "parsed_answer": {
          "dose_per_dose_mg": 85,
          "volume_per_dose_mL": null,
          "frequency": "q12h",
          "max_daily_mg": 170,
          "rounding": "nearest whole mg",
          "calc_rule": "1 mg/kg q12h",
          "citations": [
            "lexi-enoxaparin-2018#dosing"
          ],
          "notes": "Enoxaparin 1 mg/kg SC q12h is the preferred regimen for acute DVT treatment in normal renal function."
        },
        "failure_types": [
          "qa_incorrect",
          "qa_incomplete"
        ]
      },
      "expected_answer": "Enoxaparin 1 mg/kg SC q12h \u2192 85 mg per dose (or 1.5 mg/kg once daily as alternative). If CrCl <30 mL/min: 1 mg/kg once daily.",
      "judge_assessment": {
        "score": 85,
        "verdict": "pass",
        "rationale": "The answer correctly provides the enoxaparin dose of 85 mg SC q12h, cites appropriate evidence chunks, and covers the required key points."
      },
      "retrieval_performance": {
        "retrieved_chunks": [
          {
            "chunk_id": "lexi-enoxaparin-2018#dosing",
            "score": 0.0,
            "rank": 1
          },
          {
            "chunk_id": "lexi-enoxaparin-2018#renal",
            "score": 0.0,
            "rank": 2
          },
          {
            "chunk_id": "lexi-enoxaparin-2018#prophylaxis",
            "score": 0.0,
            "rank": 3
          }
        ],
        "relevant_chunks_found": [
          "lexi-enoxaparin-2018#dosing",
          "lexi-enoxaparin-2018#renal"
        ],
        "essential_chunks_missed": []
      },
      "key_points_missing": [
        "Alternative 1.5 mg/kg q24h",
        "Per-dose 85 mg for 85 kg",
        "Renal adjustment for CrCl <30"
      ]
    },
    {
      "question_id": "q006",
      "question": "Type 2 diabetes patient with eGFR 28 mL/min/1.73 m\u00b2. Can we use metformin?",
      "llm_response": {
        "raw_answer": "{\"dose_per_dose_mg\":null,\"volume_per_dose_mL\":null,\"frequency\":\"\",\"max_daily_mg\":null,\"rounding\":\"\",\"calc_rule\":\"Metformin contraindicated if eGFR <30 mL/min/1.73 m\u00b2\",\"citations\":[\"lexi-metformin-2018#renal\"],\"notes\":\"Metformin is contraindicated in this patient due to eGFR <30 mL/min/1.73 m\u00b2.\"}",
        "parsed_answer": {
          "dose_per_dose_mg": null,
          "volume_per_dose_mL": null,
          "frequency": "",
          "max_daily_mg": null,
          "rounding": "",
          "calc_rule": "Metformin contraindicated if eGFR <30 mL/min/1.73 m\u00b2",
          "citations": [
            "lexi-metformin-2018#renal"
          ],
          "notes": "Metformin is contraindicated in this patient due to eGFR <30 mL/min/1.73 m\u00b2."
        },
        "failure_types": [
          "qa_incorrect",
          "qa_incomplete",
          "e2e_low_quality"
        ]
      },
      "expected_answer": "No\u2014contraindicated at eGFR <30. If 30\u201345, generally avoid initiation; if continuing, reduce dose and monitor. Avoid in hepatic impairment.",
      "judge_assessment": {
        "score": 70,
        "verdict": "manual_review",
        "rationale": "The model correctly identifies metformin as contraindicated at eGFR <30, but it only cites one allowed chunk and misses coverage for the recommendation to avoid initiation at eGFR 30\u201345 and the need to reduce and monitor if continuing. Additionally, it does not mention the hepatic impairment contraindication, which is critical."
      },
      "retrieval_performance": {
        "retrieved_chunks": [
          {
            "chunk_id": "lexi-metformin-2018#renal",
            "score": 0.0,
            "rank": 1
          },
          {
            "chunk_id": "lexi-metformin-2018#contra",
            "score": 0.0,
            "rank": 2
          },
          {
            "chunk_id": "lexi-metformin-2018#old-crcl60",
            "score": 0.0,
            "rank": 3
          }
        ],
        "relevant_chunks_found": [
          "lexi-metformin-2018#contra",
          "lexi-metformin-2018#renal"
        ],
        "essential_chunks_missed": []
      },
      "key_points_missing": [
        "30\u201345: avoid initiation; if continuing, reduce & monitor",
        "Hepatic impairment: avoid (lactic acidosis risk)"
      ]
    },
    {
      "question_id": "q007",
      "question": "Uncomplicated cystitis: Should we use nitrofurantoin if eGFR is 25?",
      "llm_response": {
        "raw_answer": "{\"dose_per_dose_mg\":null,\"volume_per_dose_mL\":null,\"frequency\":\"\",\"max_daily_mg\":null,\"rounding\":\"\",\"calc_rule\":\"Avoid if eGFR/CrCl <30 mL/min\",\"citations\":[\"lexi-nitrofurantoin-2018#renal\",\"lexi-nitrofurantoin-2018#contra\"],\"notes\":\"Nitrofurantoin is contraindicated in significant renal dysfunction.\"}",
        "parsed_answer": {
          "dose_per_dose_mg": null,
          "volume_per_dose_mL": null,
          "frequency": "",
          "max_daily_mg": null,
          "rounding": "",
          "calc_rule": "Avoid if eGFR/CrCl <30 mL/min",
          "citations": [
            "lexi-nitrofurantoin-2018#renal",
            "lexi-nitrofurantoin-2018#contra"
          ],
          "notes": "Nitrofurantoin is contraindicated in significant renal dysfunction."
        },
        "failure_types": [
          "qa_incorrect",
          "qa_incomplete"
        ]
      },
      "expected_answer": "Avoid nitrofurantoin when eGFR/CrCl <30 mL/min due to low urinary levels and toxicity risk.",
      "judge_assessment": {
        "score": 85,
        "verdict": "pass",
        "rationale": "The model correctly advises against nitrofurantoin use with eGFR <30, cites appropriate chunks, and provides rationale for the contraindication."
      },
      "retrieval_performance": {
        "retrieved_chunks": [
          {
            "chunk_id": "lexi-nitrofurantoin-2018#renal",
            "score": 0.0,
            "rank": 1
          },
          {
            "chunk_id": "lexi-nitrofurantoin-2018#contra",
            "score": 0.0,
            "rank": 2
          },
          {
            "chunk_id": "lexi-nitrofurantoin-2018#prophylaxis",
            "score": 0.0,
            "rank": 3
          }
        ],
        "relevant_chunks_found": [
          "lexi-nitrofurantoin-2018#contra",
          "lexi-nitrofurantoin-2018#renal"
        ],
        "essential_chunks_missed": []
      },
      "key_points_missing": [
        "Rationale: efficacy/toxicity",
        "List common contraindications where relevant"
      ]
    },
    {
      "question_id": "q008",
      "question": "Patient on warfarin needs TMP-SMX for UTI. Any interaction and what should we do?",
      "llm_response": {
        "raw_answer": "{\"dose_per_dose_mg\":null,\"volume_per_dose_mL\":null,\"frequency\":\"\",\"max_daily_mg\":null,\"rounding\":\"\",\"calc_rule\":\"\",\"citations\":[\"lexi-warfarin-2018#ddi-tmp-smx\"],\"notes\":\"Avoid TMP-SMX with warfarin due to major interaction; prefer alternatives or monitor INR closely.\"}",
        "parsed_answer": {
          "dose_per_dose_mg": null,
          "volume_per_dose_mL": null,
          "frequency": "",
          "max_daily_mg": null,
          "rounding": "",
          "calc_rule": "",
          "citations": [
            "lexi-warfarin-2018#ddi-tmp-smx"
          ],
          "notes": "Avoid TMP-SMX with warfarin due to major interaction; prefer alternatives or monitor INR closely."
        },
        "failure_types": [
          "retrieval_irrelevant",
          "qa_incorrect",
          "qa_incomplete",
          "e2e_low_quality"
        ]
      },
      "expected_answer": "Major interaction (CYP2C9 inhibition + gut flora). Avoid if possible; otherwise increase INR monitoring and reduce warfarin dose.",
      "judge_assessment": {
        "score": 85,
        "verdict": "pass",
        "rationale": "The model correctly identifies the major interaction and appropriate actions, citing the allowed chunk. All key points are covered."
      },
      "retrieval_performance": {
        "retrieved_chunks": [
          {
            "chunk_id": "lexi-warfarin-2018#ddi-tmp-smx",
            "score": 0.0,
            "rank": 1
          },
          {
            "chunk_id": "lexi-warfarin-2018#ddi-cephalexin",
            "score": 0.0,
            "rank": 2
          }
        ],
        "relevant_chunks_found": [
          "lexi-warfarin-2018#ddi-tmp-smx"
        ],
        "essential_chunks_missed": []
      },
      "key_points_missing": [
        "Mechanism: CYP2C9 inhibition + gut flora",
        "Severity: major",
        "Action: avoid or close INR monitoring with dose reduction"
      ]
    },
    {
      "question_id": "q009",
      "question": "Patient on atorvastatin needs clarithromycin. What\u2019s the risk and action?",
      "llm_response": {
        "raw_answer": "{\"dose_per_dose_mg\":null,\"volume_per_dose_mL\":null,\"frequency\":\"\",\"max_daily_mg\":null,\"rounding\":\"\",\"calc_rule\":\"\",\"citations\":[\"lexi-atorvastatin-2018#ddi-macrolides\"],\"notes\":\"Avoid clarithromycin due to increased myopathy/rhabdomyolysis risk.\"}",
        "parsed_answer": {
          "dose_per_dose_mg": null,
          "volume_per_dose_mL": null,
          "frequency": "",
          "max_daily_mg": null,
          "rounding": "",
          "calc_rule": "",
          "citations": [
            "lexi-atorvastatin-2018#ddi-macrolides"
          ],
          "notes": "Avoid clarithromycin due to increased myopathy/rhabdomyolysis risk."
        },
        "failure_types": [
          "retrieval_irrelevant",
          "qa_incorrect",
          "qa_incomplete",
          "e2e_low_quality"
        ]
      },
      "expected_answer": "Major interaction (strong CYP3A4 inhibitor). Avoid coadministration; if unavoidable, hold atorvastatin or limit to the lowest dose and monitor for myopathy.",
      "judge_assessment": {
        "score": 70,
        "verdict": "manual_review",
        "rationale": "The model correctly identifies the major interaction and cites the appropriate chunk, but it fails to explicitly mention the mechanism and action in the notes as required. The notes imply the action but do not clearly state it, leading to a deduction for evidence coverage."
      },
      "retrieval_performance": {
        "retrieved_chunks": [
          {
            "chunk_id": "lexi-atorvastatin-2018#ddi-macrolides",
            "score": 0.0,
            "rank": 1
          },
          {
            "chunk_id": "lexi-atorvastatin-2018#ddi-azithro",
            "score": 0.0,
            "rank": 2
          }
        ],
        "relevant_chunks_found": [
          "lexi-atorvastatin-2018#ddi-macrolides"
        ],
        "essential_chunks_missed": []
      },
      "key_points_missing": [
        "Mechanism: strong CYP3A4 inhibition",
        "Severity: major",
        "Action: avoid; if unavoidable hold or use lowest dose with monitoring"
      ]
    },
    {
      "question_id": "q010",
      "question": "Starting linezolid in a patient on sertraline. Is this safe?",
      "llm_response": {
        "raw_answer": "```json\n{\"dose_per_dose_mg\":null,\"volume_per_dose_mL\":null,\"frequency\":\"\",\"max_daily_mg\":null,\"rounding\":\"\",\"calc_rule\":\"\",\"citations\":[\"lexi-linezolid-2018#ddi-ssri\"],\"notes\":\"Avoid linezolid with sertraline due to serotonin syndrome risk.\"}\n```",
        "parsed_answer": "```json\n{\"dose_per_dose_mg\":null,\"volume_per_dose_mL\":null,\"frequency\":\"\",\"max_daily_mg\":null,\"rounding\":\"\",\"calc_rule\":\"\",\"citations\":[\"lexi-linezolid-2018#ddi-ssri\"],\"notes\":\"Avoid linezolid with sertraline due to serotonin syndrome risk.\"}\n```",
        "failure_types": [
          "retrieval_irrelevant",
          "qa_incorrect",
          "qa_incomplete",
          "e2e_low_quality"
        ]
      },
      "expected_answer": "Major interaction: risk of serotonin syndrome (linezolid has MAOI activity). Avoid; if benefits outweigh risks, withhold SSRI or monitor very closely.",
      "judge_assessment": {
        "score": 0,
        "verdict": "manual_review",
        "rationale": "Judge response not JSON: ```json\n{\n  \"score\": 80,\n  \"verdict\": \"manual_review\",\n  \"rationale\": \"The model correctly identifies the major interact..."
      },
      "retrieval_performance": {
        "retrieved_chunks": [
          {
            "chunk_id": "lexi-linezolid-2018#ddi-ssri",
            "score": 0.0,
            "rank": 1
          },
          {
            "chunk_id": "lexi-linezolid-2018#ddi-penicillins",
            "score": 0.0,
            "rank": 2
          }
        ],
        "relevant_chunks_found": [
          "lexi-linezolid-2018#ddi-ssri"
        ],
        "essential_chunks_missed": []
      },
      "key_points_missing": [
        "Mechanism: MAOI activity \u2192 \u2191serotonin",
        "Severity: major",
        "Action: avoid; or stop SSRI/close monitoring if unavoidable"
      ]
    },
    {
      "question_id": "q011",
      "question": "Patient on digoxin will start amiodarone. What\u2019s the interaction management?",
      "llm_response": {
        "raw_answer": "{\"dose_per_dose_mg\":null,\"volume_per_dose_mL\":null,\"frequency\":\"\",\"max_daily_mg\":null,\"rounding\":\"\",\"calc_rule\":\"Reduce digoxin dose by 30\u201350% due to P-gp inhibition by amiodarone.\",\"citations\":[\"lexi-digoxin-2018#ddi-amio\"],\"notes\":\"Monitor serum digoxin levels, renal function, and ECG.\"}",
        "parsed_answer": {
          "dose_per_dose_mg": null,
          "volume_per_dose_mL": null,
          "frequency": "",
          "max_daily_mg": null,
          "rounding": "",
          "calc_rule": "Reduce digoxin dose by 30\u201350% due to P-gp inhibition by amiodarone.",
          "citations": [
            "lexi-digoxin-2018#ddi-amio"
          ],
          "notes": "Monitor serum digoxin levels, renal function, and ECG."
        },
        "failure_types": [
          "retrieval_irrelevant",
          "qa_incomplete"
        ]
      },
      "expected_answer": "Major interaction (P-gp inhibition). Reduce digoxin dose by ~30\u201350% and monitor levels/ECG.",
      "judge_assessment": {
        "score": 75,
        "verdict": "manual_review",
        "rationale": "The model correctly identifies the interaction and cites the appropriate chunk, but it lacks specific details on the mechanism and severity of the interaction, which are critical for completeness."
      },
      "retrieval_performance": {
        "retrieved_chunks": [
          {
            "chunk_id": "lexi-digoxin-2018#ddi-amio",
            "score": 0.0,
            "rank": 1
          },
          {
            "chunk_id": "lexi-digoxin-2018#ddi-verapamil",
            "score": 0.0,
            "rank": 2
          }
        ],
        "relevant_chunks_found": [
          "lexi-digoxin-2018#ddi-amio"
        ],
        "essential_chunks_missed": []
      },
      "key_points_missing": [
        "Mechanism: P-gp inhibition \u2192 \u2191digoxin",
        "Severity: major"
      ]
    },
    {
      "question_id": "q012",
      "question": "COVID-19 patient asks for Paxlovid dosing and interaction checks.",
      "llm_response": {
        "raw_answer": "{\n    \"dose_per_dose_mg\": null,\n    \"volume_per_dose_mL\": null,\n    \"frequency\": \"\",\n    \"max_daily_mg\": null,\n    \"rounding\": \"\",\n    \"calc_rule\": \"Context predates COVID-19 therapies\",\n    \"citations\": [\"kb-scope-2018#covid-absent\"],\n    \"notes\": \"Refer to current guidance for Paxlovid dosing.\"\n}",
        "parsed_answer": {
          "dose_per_dose_mg": null,
          "volume_per_dose_mL": null,
          "frequency": "",
          "max_daily_mg": null,
          "rounding": "",
          "calc_rule": "Context predates COVID-19 therapies",
          "citations": [
            "kb-scope-2018#covid-absent"
          ],
          "notes": "Refer to current guidance for Paxlovid dosing."
        },
        "failure_types": [
          "retrieval_miss",
          "retrieval_irrelevant",
          "qa_incorrect",
          "qa_incomplete",
          "e2e_low_quality"
        ]
      },
      "expected_answer": "ABSTAIN. Not in \u22642018 corpus; recency-sensitive therapy. Advise consulting current guidance/pharmacist.",
      "judge_assessment": {
        "score": 80,
        "verdict": "manual_review",
        "rationale": "The model correctly abstains and cites an allowed chunk, but it does not explicitly state the reason for abstention as required, which affects the completeness of the response."
      },
      "retrieval_performance": {
        "retrieved_chunks": [
          {
            "chunk_id": "kb-scope-2018#covid-absent",
            "score": 0.0,
            "rank": 1
          }
        ],
        "relevant_chunks_found": [],
        "essential_chunks_missed": []
      },
      "key_points_missing": [
        "Explicit abstention",
        "Sets recency_risk = true",
        "Advises pharmacist/current guidance"
      ]
    },
    {
      "question_id": "q013",
      "question": "What is the current first-line pharmacologic therapy per latest hypertension guidelines?",
      "llm_response": {
        "raw_answer": "{\"dose_per_dose_mg\":null,\"volume_per_dose_mL\":null,\"frequency\":\"\",\"max_daily_mg\":null,\"rounding\":\"\",\"calc_rule\":\"\",\"citations\":[\"lexi-hypertension-2014#jnc8\"],\"notes\":\"JNC8 (2014) is outdated for current hypertension guidelines.\"}",
        "parsed_answer": {
          "dose_per_dose_mg": null,
          "volume_per_dose_mL": null,
          "frequency": "",
          "max_daily_mg": null,
          "rounding": "",
          "calc_rule": "",
          "citations": [
            "lexi-hypertension-2014#jnc8"
          ],
          "notes": "JNC8 (2014) is outdated for current hypertension guidelines."
        },
        "failure_types": [
          "qa_incorrect",
          "qa_incomplete",
          "e2e_low_quality"
        ]
      },
      "expected_answer": "ABSTAIN if asked for \u2018current\u2019 guidance (2018 corpus includes JNC8/2014). Flag recency risk.",
      "judge_assessment": {
        "score": 85,
        "verdict": "pass",
        "rationale": "The model correctly abstained from providing current guidelines, recognized the outdated nature of JNC8, and cited the appropriate chunk. Recency risk was flagged."
      },
      "retrieval_performance": {
        "retrieved_chunks": [
          {
            "chunk_id": "lexi-hypertension-2014#jnc8",
            "score": 0.0,
            "rank": 1
          }
        ],
        "relevant_chunks_found": [
          "lexi-hypertension-2014#jnc8"
        ],
        "essential_chunks_missed": []
      },
      "key_points_missing": [
        "Explicit abstention for \u2018current\u2019 guideline ask",
        "Sets recency_risk = true"
      ]
    }
  ]
}